Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes
Gordon C. Weir, Jason L. Gaglia, Susan Bonner‐Weir
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 3, pp. 249-256
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Biomarkers of aging
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 197
The Influence of Different Types of Diabetes on Vascular Complications
Jiahua Wei, Jiaxing Tian, Cheng Tang, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 46
Selenium Nanodots (SENDs) as Antioxidants and Antioxidant‐Prodrugs to Rescue Islet β Cells in Type 2 Diabetes Mellitus by Restoring Mitophagy and Alleviating Endoplasmic Reticulum Stress
Qiong Huang, Zerun Liu, Yunrong Yang, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 28
THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic β-cell function and preserving β-cell mass
Yuqing Zhang, Shan Han, Congcong Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges
Kanghong Hu, Huizhong Huang, Hanluo Li, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 25
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 25
Understanding the cause of type 2 diabetes
Roy Taylor
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 9, pp. 664-673
Closed Access | Times Cited: 15
Coffee and Lower Risk of Type 2 Diabetes: Arguments for a Causal Relationship
Hubert Kolb, Stéphan Martin, Kerstin Kempf
Nutrients (2021) Vol. 13, Iss. 4, pp. 1144-1144
Open Access | Times Cited: 53
Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies
Safia Costes, Gyslaine Bertrand, Magalie A. Ravier
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5303-5303
Open Access | Times Cited: 46
Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes
Debarun Patra, Dipanjan Banerjee, Palla Ramprasad, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 20
First-phase insulin secretion: can its evaluation direct therapeutic approaches?
Gianfranco Di Giuseppe, Gea Ciccarelli, Laura Soldovieri, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 4, pp. 216-230
Open Access | Times Cited: 19
The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
Joon Kim, Chang‐Myung Oh, Hyeongseok Kim
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2589-2589
Open Access | Times Cited: 18
Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus
Jian Zhu, Junfeng Han, Liehua Liu, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110568-110568
Open Access | Times Cited: 17
Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes
Stéphane Dalle, Amar Abderrahmani, Éric Renard
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes
Daxin Cui, Xingrong Feng, Si-Man Lei, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 7, pp. 791-805
Open Access | Times Cited: 7
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
Muhammad Abdul‐Ghani, Curtiss Puckett, John M. Adams, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 433-439
Open Access | Times Cited: 46
Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review)
Weixuan Wang, Xin Zhong, Jiao Guo
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 6
Open Access | Times Cited: 34
The Role of Beta Cell Recovery in Type 2 Diabetes Remission
Mara Suleiman, Lorella Marselli, Miriam Cnop, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7435-7435
Open Access | Times Cited: 26
β-cell dynamics in type 2 diabetes and in dietary and exercise interventions
Cheng-an Lv, Yuchen Sun, Zhe Yu Zhang, et al.
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 7
Open Access | Times Cited: 26
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes
Teresa Mezza, Pietro Manuel Ferraro, Gianfranco Di Giuseppe, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 12
Open Access | Times Cited: 32
Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond
Takaaki Murakami, Hiroyuki Fujimoto, Nobuya Inagaki
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 31
Targeting β-cell dedifferentiation and transdifferentiation: opportunities and challenges
Wenrui Wang, Chuan Zhang
Endocrine Connections (2021) Vol. 10, Iss. 8, pp. R213-R228
Open Access | Times Cited: 30
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Akinobu Nakamura, Kazuno Omori, Yasuo Terauchi
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 10, pp. 2199-2206
Closed Access | Times Cited: 28
Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review
Daniel Jamrozik, Weronika Borymska, Ilona Kaczmarczyk‐Sedlak
Foods (2022) Vol. 11, Iss. 14, pp. 2134-2134
Open Access | Times Cited: 20
The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification
Feng Guo, Lan Yao, Wenxiang Zhang, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116222-116222
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top